IRIS
BASSETTI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.597
EU - Europa 4.216
AS - Asia 2.026
Continente sconosciuto - Info sul continente non disponibili 25
SA - Sud America 18
AF - Africa 10
OC - Oceania 4
Totale 29.896
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.567
UA - Ucraina 1.360
CN - Cina 941
IT - Italia 663
SE - Svezia 635
DE - Germania 613
TR - Turchia 456
SG - Singapore 382
IE - Irlanda 272
FI - Finlandia 204
RU - Federazione Russa 170
VN - Vietnam 159
GB - Regno Unito 125
NL - Olanda 47
BE - Belgio 34
IN - India 31
CA - Canada 28
EU - Europa 25
FR - Francia 19
CZ - Repubblica Ceca 16
KR - Corea 15
HK - Hong Kong 14
AT - Austria 11
RS - Serbia 11
PL - Polonia 10
AR - Argentina 7
IR - Iran 7
BR - Brasile 5
HU - Ungheria 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
AO - Angola 4
RO - Romania 4
JP - Giappone 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
PE - Perù 3
CH - Svizzera 2
ES - Italia 2
ET - Etiopia 2
GH - Ghana 2
LU - Lussemburgo 2
MM - Myanmar 2
MX - Messico 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
GR - Grecia 1
IL - Israele 1
KG - Kirghizistan 1
MA - Marocco 1
NG - Nigeria 1
NO - Norvegia 1
PT - Portogallo 1
PY - Paraguay 1
SA - Arabia Saudita 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 29.896
Salva come PNG Salva come JPEG
Città #
Fairfield 3.666
Woodbridge 3.348
Houston 2.246
Ann Arbor 1.932
Ashburn 1.606
Seattle 1.465
Chandler 1.364
Wilmington 1.308
Cambridge 1.302
Dearborn 815
Jacksonville 685
Izmir 453
Boardman 431
Beijing 324
Singapore 303
Princeton 299
Dublin 269
Udine 189
San Diego 175
Des Moines 160
Dong Ket 158
Falls Church 94
Andover 74
Norwalk 64
Hefei 59
Nanjing 55
Ogden 51
Kunming 39
Guangzhou 38
Milan 38
Brussels 34
Munich 34
Redmond 32
Shanghai 32
Grafing 30
Jinan 28
Fuzhou 26
Phoenix 25
New York 23
Trieste 22
Fremont 20
Redwood City 18
Nanchang 17
Venezia 17
Brno 16
Zhengzhou 16
Helsinki 14
Hong Kong 14
Los Angeles 14
Rome 14
Wuhan 14
Dallas 13
Maserada Sul Piave 13
Turin 13
Hanover 12
Hebei 12
Washington 12
Toronto 11
Changsha 10
Ottawa 10
Shenyang 10
Shenzhen 10
Brescia 9
London 9
Taizhou 9
Vienna 9
Warsaw 9
Indiana 8
Naples 8
Sezze 8
Tappahannock 8
Buenos Aires 7
Chongqing 7
Jiaxing 7
Lappeenranta 7
Palermo 7
Simi Valley 7
Chengdu 6
Grugliasco 6
Xi'an 6
Xian 6
Baotou 5
Bologna 5
Bolzano 5
Florence 5
Genoa 5
Hangzhou 5
Moscow 5
Pune 5
Clifton 4
Lozzo di Cadore 4
Monastir 4
Padova 4
Petritoli 4
Torre Del Greco 4
Wenzhou 4
Auburn Hills 3
Budapest 3
Chicago 3
Dubai 3
Totale 23.819
Salva come PNG Salva come JPEG
Nome #
Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: An individual participant data meta-analysis 214
Exploring ecological modelling to investigate factors governing the colonization success in nosocomial environment of Candida albicans and other pathogenic yeasts 212
A regional approach to Antimicrobial Stewardship: the Friuli Venezia Giulia program 210
Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae? 195
Antibiotic-resistant Pseudomonas aeruginosa: Focus on care in patients receiving assisted ventilation 189
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 186
The management of multidrug-resistant enterobacteriaceae 180
Delafloxacin for the treatment of respiratory and skin infections 163
Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant 159
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 156
Terapia e profilassi delle infezioni 156
Hot topics in necrotising skin and soft tissue infections 151
Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamaseproducing Enterobacteriaceae in haematological patients with neutropaenia: A study protocol for a retrospective observational study (BICAR) 150
Task force on management and prevention of Acinetobacter baumannii infections in the ICU 148
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 148
Adherence to international and national recommendations for the prevention of surgical site infections in Italy: Results from an observational prospective study in elective surgery 145
Current and future treatment options for infections caused by multidrug-resistant Gram-negative pathogens 141
Ceftolozane/tazobactam for the treatment of serious P. aeruginosa infections: a multicenter nationwide clinical experience 141
Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15) 138
Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: A critical agenda 138
New therapeutic options for respiratory tract infections 138
Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients 137
Year in review in Intensive Care Medicine 2013: II. Sedation, invasive and noninvasive ventilation, airways, ARDS, ECMO, family satisfaction, end-of-life care, organ donation, informed consent, safety, hematological issues in critically ill patients 137
DALI: Defining antibiotic levels in intensive care unit patients: Are current ß-lactam antibiotic doses sufficient for critically ill patients? 136
Safety of long-term use of linezolid: Results of an open-label study 136
Community-acquired Legionella Pneumonia in the intensive care unit: Impact on survival of combined antibiotic therapy 136
Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update 136
Variable incidence of candidemia in patients admitted to ICUs or medical wards of large tertiary-care Italian hospitals 136
Focus on optimization of early antimicrobial therapy in ICU-acquired infections 135
"Excess mortality" and colistin-tigecycline for extensively drug-resistant Acinetobacter baumannii bacteremia 135
First report of endocarditis by Gluconobacter spp. in a patient with a history of intravenous-drug abuse 135
Is first-line antimicrobial therapy still adequate to treat MRSA in the ICU? A report from a highly endemic country 135
Resistance mechanisms and epidemiology of multiresistant pathogens in europe and efficacy of tigecycline in observational studies 134
The role of dalbavancin in skin and soft tissue infections 134
Persistent viremia and urine shedding of tick-borne encephalitis virus in an infected immunosuppressed patient from a new epidemic cluster in North-Eastern Italy 133
The role of methicillin-resistant Staphylococcus aureus in skin and soft tissue infections 133
Association between source control and mortality in 258 patients with intra-abdominal candidiasis: a retrospective multi-centric analysis comparing intensive care versus surgical wards in Spain 133
Serological and T Cell Responses after Varicella Zoster Virus Vaccination in HIV-Positive Patients Undergoing Renal Dialysis 133
Development of novel antibacterial drugs to combat multiple resistant organisms 131
Epidemiology, species distribution, antifungal susceptibility, and outcome of Candidemia across five sites in Italy and Spain 131
Management of reduced vaccine coverage due to 6 years of failure to vaccinate: The Codroipo case, Italy 131
Impact of new treatment options for hepatitis c virus infection in liver transplantation 131
Recurrent seizures during acute acquired toxoplasmosis in an immunocompetent traveller returning from Africa 130
Characteristics of an ideal nebulized antibiotic for the treatment of pneumonia in the intubated patient 130
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement 130
Focus on antimicrobial use in the era of increasing antimicrobial resistance in ICU 129
Infezioni delle vie urinarie: appropriatezza in antibioticoterapia 128
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort 128
Year in review in Intensive Care Medicine 2013: III. Sepsis, infections, respiratory diseases, pediatrics 128
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure 128
Linezolid underexposure in a patient co-treated with venlafaxine 127
Tick-borne encephalitis in North-East Italy: A 14-year retrospective study, January 2000 to December 2013 127
Diagnosis and management of invasive candidiasis in the ICU: An updated approach to an old enemy 127
Are prophylactic antifungals in highly colonized patients safe and effective? 127
Antiretroviral blood levels in HIV/HCV-coinfected patients with cirrhosis after liver transplant: A report of three cases 126
Global survey on nebulization of antimicrobial agents in mechanically ventilated patients: A call for international guidelines 126
Overview of Fungal Infections - The Italian Experience 126
Current and future therapies for invasive aspergillosis 125
Efficacy of tigecycline for the treatment of complicated intraabdominal infections in real-life clinical practice from five european observational studies 125
Advances in antibiotic therapy in the critically ill 125
Is there a future for tigecycline? 125
Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: Lessons from the DALI Study 125
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 125
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. 124
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study-authors' response 124
New therapeutic options for skin and soft tissue infections 124
Predictive models for identification of hospitalized patients harboring KPC-producing klebsiella pneumoniae 124
Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study 124
Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections 124
Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics 123
Prosthetic joints: Shining lights on challenging blind spots 123
Ceftolozane/tazobactam: place in therapy 123
Schistosomiasis screening of travelers from italy with possible exposure in Corsica, France 122
Critically ill migrants with infection: diagnostic considerations for intensive care physicians in Europe 122
New antibiotics for bad bugs: Where are we? 122
18F-Fluorodeoxyglucose positron emission tomography and infectious diseases: current applications and future perspectives 122
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study 122
Is empiric daptomycin effective in reducing mortality in Staphylococcus aureus bacteraemia? A real-life experience 121
Intratracheal administration of antimicrobial agents in mechanically ventilated adults: An international survey on delivery practices and safety 121
Anidulafungin for the treatment of candidaemia caused by Candida parapsilosis: Analysis of pooled data from six prospective clinical studies 121
Safety profiles of old and new antimicrobials for the treatment of MRSA infections 120
SDD and colistin resistance: End of a dream? 120
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: A meta-analysis of individual participant data 120
Predicting the occurrence of embolic events: An analysis of 1456 episodes of infective endocarditis from the Italian Study on Endocarditis (SEI) 120
Patient specific risk stratification for antimicrobial resistance and possible treatment strategies in gram-negative bacterial infections 120
Gitelman syndrome disclosed by calcium pyrophosphate deposition disease: Early diagnosis by ultrasonographic study 119
Antibiotic stewardship challenges in the management of community-acquired infections for prevention of escalating antibiotic resistance 119
Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria 119
Ten old antibiotics that will never disappear 119
MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for management 119
Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study 118
New antibiotics and antimicrobial combination therapy for the treatment of gram-negative bacterial infections 118
Determination of PCT on admission is a useful tool for the assessment of disease severity in travelers with imported Plasmodium falciparum malaria 118
Treatment of consecutive episodes of multidrug-resistant bacterial pleurisy with different aetiology in a heart transplant candidate: Proof of concept of pharmacokinetic/pharmacodynamic optimisation of antimicrobial therapy at the infection site 118
Prescription behaviours for tigecycline in real-life clinical practice from five European observational studies 117
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia 117
Potential role for telavancin in bacteremic infections due to gram-positive pathogens: Focus on staphylococcus aureus 117
Is MIC increase of meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae correlated with the increase of resistance rates against some other antibiotics with Gram-negative activity? 117
Nebulization of antimicrobial agents in mechanically ventilated adults in 2017: an international cross-sectional survey 117
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 117
Totale 13.398
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.251
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.251
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.108 0 0 0 0 0 0 1.204 1.004 855 412 195 438
2020/20215.163 164 589 236 592 341 663 329 524 523 246 474 482
2021/20222.808 175 220 223 157 55 197 219 104 49 443 502 464
2022/20233.147 340 150 42 411 353 902 1 230 524 35 77 82
2023/2024829 160 103 40 22 188 73 33 42 84 34 14 36
2024/20251.346 137 357 226 220 138 259 9 0 0 0 0 0
Totale 31.117